Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Fenghua Pharmaceutical is a Chinese pharmaceutical company headquartered in the Fengxian District of Shanghai. Established in 1993, the company specializes in the research, development, and large-scale production of chemical drugs and traditional Chinese medicine (TCM) preparations. Its product portfolio is heavily focused on over-the-counter (OTC) medications for respiratory ailments, including widely used treatments for the common cold and influenza. Additionally, the company manufactures essential medicines for chronic conditions, such as metformin for the management of type 2 diabetes. Shanghai Fenghua Pharmaceutical operates modern, GMP-certified manufacturing facilities to ensure compliance with national quality standards. The company serves as a key supplier within the domestic Chinese healthcare market, providing affordable therapeutic options for primary care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海枫华制药.